EMPIRE CONSULTING GROUP for CRISPR THERAPEUTICS INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Copyright/Patent/Trademark CPT
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Health Issues HCR
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Medicare/Medicaid MMM
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Insurance INS
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Pharmacy PHA
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Medical/Disease Research/Clinical Labs MED
Value-based payment models, new payment models, CMS National Coverage Determinations, drug approval pathways under the FDA User Fee programs, and drug development incentives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHAKA BURGESS New | — |
| LAVITA STRICKLAND LEGRYS New | DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel, Jordan Immigration Comm'n-Legal Counsel. |
| MIKE MCKAY New | Sr. Advisor, Rep. Greg Meeks (D-NY) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | Switzerland | Switzerland | 100.0% | $100,000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| CRISPR THERAPEUTICS AG | Zug, CH |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.